Topiramate add-on treatment associated with normalization of prolactin levels in a patient with schizophrenia
Yinglin Huang,1,2 Huan Ma,1 Yuan Wang,2 Miao Peng,2 Gang Zhu1 1Department of Psychiatry, The First Affiliated Hospital of China Medical University, 2Department of Psychiatry, Shengjing Hospital of China Medical University, Shenyang, China Abstract: Topiramate has been used increasingly in the mana...
Enregistré dans:
Auteurs principaux: | Huang Y, Ma H, Wang Y, Peng M, Zhu G |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Dove Medical Press
2017
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/7fce3565f68f4be1b8643d1dd3232f3d |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Efficacy and tolerability of topiramate-augmentation therapy for schizophrenia: a systematic review and meta-analysis of randomized controlled trials
par: Okuyama Y, et autres
Publié: (2016) -
Influence of olanzapine on serum prolactin levels and BMI in female patients with schizophrenia
par: Yang F, et autres
Publié: (2018) -
Comprehensive review of visual defects reported with topiramate
par: Ford L, et autres
Publié: (2017) -
Review of topiramate for the treatment of epilepsy in elderly patients
par: BR Sommer, et autres
Publié: (2010) -
Aripiprazole combination for reversal of paliperidone-induced increase in prolactin level
par: Zhi P, et autres
Publié: (2018)